 Written by a licensed veterinarian and medical advisor to pet brands. All guidance reflects current veterinary standards and marketing compliance considerations. Pet supplement marketing is one of the trickiest lanes in the pet industry. The brand wants compelling copy. The marketing team wants conversion. The product team wants to communicate benefits clearly. The veterinarian wants accuracy. The regulatory team wants fewer problems. And somewhere in the middle, one phrase can quietly shift a product from “wellness support” into “this sounds like an unapproved animal drug.” 😬 When a pet supplement is marketed as if it can diagnose, treat, mitigate, cure, or prevent disease, the brand may create risk with FDA-CVM, FTC, NAD, state feed regulators, retailers, platforms, and veterinary partners. FDA states that unapproved animal drugs are new animal drugs without legal marketing status and that it is illegal to market unapproved new animal drugs without appropriate FDA review and legal status. That matters for pet supplement brands because when supplement marketing suggests a product is intended to treat, prevent, cure, mitigate, or manage disease, the product can begin to look less like a wellness supplement and more like an unapproved animal drug in the eyes of regulators. This is why pet supplement claims need more than creativity. They need veterinary, scientific, and regulatory-aligned review before they reach the public. This blog posts explores all the regulatory lanes that pet supplement claims need to successful navigate to stay credible and compliant. Need help translating supplement benefits into compliant, credible marketing language? That is exactly what a veterinary claims review is designed to do. FDA-CVM: The “Do Not Market a Supplement Like a Drug” LaneFDA-CVM is the U.S. Food and Drug Administration’s Center for Veterinary Medicine. For pet supplement brands, FDA-CVM becomes especially important when marketing claims suggest a product is intended to treat or manage disease. A product can move into risky territory when claims suggest it helps with conditions such as:
A claim like “supports normal joint mobility” is very different from “treats arthritis pain.” A claim like “supports calm behavior during normal stressors” is very different from “manages anxiety.” A claim like “supports a normal inflammatory response” is very different from “reduces chronic inflammation.” FDA-CVM can issue warning letters when it finds significant regulatory violations, and FDA has specifically warned companies for selling animal products promoted for unapproved drug uses. Possible FDA-CVM consequences may include warning letters, required claim changes, label revisions, website changes, product detention, seizure, injunction, referral to the Department of Justice, and reputational damage with retailers, veterinarians, and investors. For a growing pet supplement brand, the practical message is simple: If your supplement copy sounds like treatment, disease management, or drug substitution, it needs review before launch. FTC: The “Prove Your Advertising Claims” LaneThe FTC, Federal Trade Commission, is focused on advertising truthfulness, consumer deception, and substantiation. Even if a brand avoids obvious disease words, FTC may still care if the overall marketing message creates a misleading impression. FTC’s Health Products Compliance Guidance says health-related claims must be truthful, not misleading, and supported by appropriate scientific evidence. 🚩 That means a pet supplement brand should be careful with claims like:
🚩 FTC does not only look at the literal words on the page. It looks at the net impression of the advertising. That includes:
These are where pet brands can get into trouble without meaning to. The product copy may be careful, but a testimonial that says “this cured my dog’s arthritis” can still create risk if the brand uses it in marketing. The practical message: Every claim needs support, and every implied claim counts. NAD: The “Your Competitor Can Challenge You” LaneNAD, the National Advertising Division, is part of the advertising industry’s self-regulatory system. It is not a government agency, but it can still create real pressure for brands. NAD reviews advertising claims and can recommend that a company modify or discontinue claims. If a company refuses to participate or does not agree to comply, NAD can refer the matter to FTC or other appropriate regulatory agencies. 🚩 For pet supplement brands, NAD risk can show up when competitors challenge claims such as:
NAD matters because many of the riskiest pet supplement claims are also the claims brands want most for conversion. That does not mean brands cannot make strong claims. It means strong claims need to be accurate, supportable, and carefully worded. NASC: The “Industry Credibility and Quality Program” LaneNASC, the National Animal Supplement Council, is not FDA. It does not replace legal compliance. But NASC can matter a great deal for animal supplement credibility. NASC’s Quality Seal program requires participating companies to have quality control procedures, an adverse event reporting and complaint system, and compliance with labeling guidelines for products and forms of labeling. If a supplement brand carries the NASC Quality Seal but uses aggressive disease claims in marketing, that can create a credibility mismatch. Consumers may not understand the details. Retailers may not care about the nuance. Veterinary partners may back away. The practical message: Quality signaling and marketing discipline need to match. State Feed Officials and AAFCO: The “Can You Sell That Label?” LaneAAFCO, the Association of American Feed Control Officials, is not an enforcement agency, but it plays an important role in animal feed and pet food labeling frameworks. AAFCO describes itself as an independent organization that guides state, federal, and international feed regulators with ingredient definitions, label standards, and laboratory standards. Its members are charged under state, local, or federal law with regulating the sale and distribution of animal feeds and animal drug remedies. For pet products positioned as supplements, functional treats, toppers, chews, powders, or food-adjacent products, state-level review can matter. Potential consequences may include:
The practical message: Your website claim is not the only risk. Your label, packaging, and registration strategy matter too. Retailers, Platforms, and Ad Accounts: The Risk Brands Feel FirstEven before FDA, FTC, or NAD gets involved, brands may run into commercial consequences. Risky claims can trigger:
Civil Litigation, Competitor Risk, and Loss of Veterinary PartnersRegulatory agencies are not the only source of risk. Pet supplement brands also need to consider competitor challenges, civil litigation, and the loss of trusted veterinary partners or influencers when claims become too aggressive. I have personally seen this happen in the pet supplement space. In my personal experience, example, a brand’s marketing claims around a pet health product became part of a broader dispute involving a larger competitor. The issue was not just whether the product had passionate customers or compelling testimonials. The problem was that certain public-facing claims created legal and credibility risk. For veterinary partners, that matters A LOT. When a brand’s messaging starts to drift into unsupported, disease-adjacent, or competitor-sensitive territory, a veterinarian may no longer feel comfortable being publicly associated with the campaign. That can mean losing the very expert voices the brand hoped would build trust. Potential consequences may include:
Most pet supplement brands do not realize they have a claims problem until a listing gets flagged, a retailer asks questions, a competitor notices, or a veterinary partner gets uncomfortable. The better time to review the language is before it goes live. The Claims Risk Ladder for Pet SupplementsHere is a simple way to think about pet supplement claim risk: Lower risk: “Supports normal mobility” Lower to moderate risk: “Supports joint comfort in active dogs” Moderate risk: “Helps dogs with stiff joints feel more comfortable” High risk: “Reduces inflammation” Very high risk: “Helps manage arthritis pain” Severe risk: “Treats arthritis naturally” Severe risk: “Clinically proven alternative to NSAIDs” The difference is not just tone. It is intended use, consumer interpretation, and substantiation. A supplement brand does not need weak copy. It needs copy that is strong inside the correct regulatory lane. Better Pet Supplement Claim SwapsHere are examples of safer, more defensible language patterns. Instead of: “Treats anxiety.” Consider: “Supports calm behavior during normal stressors.” Instead of: “Reduces chronic inflammation.” Consider: “Supports a normal inflammatory response.” Instead of: “Helps dogs with arthritis.” Consider: “Supports joint comfort, mobility, and normal activity.” Instead of: “Prevents UTIs.” Consider: “Supports normal urinary tract health.” Instead of: “Heals the gut.” Consider: “Supports normal digestive function and stool quality.” These swaps are not magic shields. They still need to match the product, ingredients, evidence, species, dosage or serving size, label, and intended use. But they move the brand away from obvious disease-treatment language and toward a more appropriate wellness-support framework. The Real Goal: Strong Claims That Hold UpThe goal is not to make pet supplement marketing boring. The goal is to make it defensible. A well-reviewed claim should be:
A careful product page paired with a disease-heavy influencer script is still a problem. A compliant label paired with an aggressive Amazon listing is still a problem. A veterinarian’s face paired with unreviewed disease claims is still a problem. For pet brands, veterinary credibility is not just about adding a DVM to a landing page. It is about making sure the science, product, claims, and marketing actually line up. The Bottom Line for Pet Supplement Brands If your supplement is marketed like a drug, the risk is bigger than “someone might not like the wording.” The brand may face FDA-CVM concerns, FTC advertising scrutiny, NAD competitor challenges, state feed issues, retailer friction, platform restrictions, and loss of veterinary trust. The better path is to build claims that are compelling, accurate, and defensible from the start. Strong pet supplement marketing should not overpromise. It should earn trust. If your pet supplement brand is preparing to launch, revise claims, work with influencers, or use veterinary authority in marketing, a claims review can help identify risky language before it becomes public-facing. This could save money, time, head aches, and litigation. And now you know. ~Dr. Sarah Wooten Before your supplement claims reach packaging, Amazon, paid ads, influencer content, or retailer review, make sure the language is accurate, supportable, and defensible.
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
AuthorDr. Sarah Wooten is a small animal veterinarian, international speaker, author, and advocate for both pets and the people who love them. With over 20 years of experience in clinical practice, media, and continuing education, she makes veterinary medicine clear, credible, and never boring. Archives
August 2026
Categories
All
|
RSS Feed